What is AndHealth?
AndHealth operates as a digital healthcare provider focused on reversing chronic diseases, including conditions such as migraines and autoimmune disorders. Based in Columbus, Ohio, the company leverages technology to deliver services aimed at improving patient outcomes and managing complex health issues. Their approach targets the root causes of chronic conditions, offering a modern alternative to traditional treatment paradigms.
How much funding has AndHealth raised?
AndHealth has raised a total of $57M across 1 funding round:
Unspecified
$57M
Unspecified (2022): $57M with participation from Health2047 Capital Partners, Twofold Ventures, American Medical Association, Kirkland & Ellis, and Francisco Partners
Key Investors in AndHealth
Health2047 Capital Partners
Health2047 Capital Partners is a fund management company focused on investing in innovative companies that aim to transform the U.S. healthcare system. With the American Medical Association as an anchor partner, they leverage unique insights to address critical needs in healthcare, particularly in chronic care and data management.
Kirkland & Ellis
Kirkland & Ellis is an international law firm that serves a broad range of clients around the world in private equity, M&A, and other corporate transactions, litigation, white collar and government disputes, restructurings, and intellectual property matters. They offer high-quality legal advice and tailored service to deliver exceptional results to their clients.
Francisco Partners
Francisco Partners is a global investment firm that focuses on private equity and credit investments in technology and technology-enabled businesses. The firm raises dedicated buyout and credit funds and typically provides control or significant minority capital for carveouts, takeprivates, growth financings, and other complex transactions across software, internet, communications, healthcare IT, and related sectors.
What's next for AndHealth?
The recent strategic investment positions AndHealth for accelerated expansion and further innovation in its service offerings. With a focus on enterprise-level solutions, the company is poised to scale its operations, enhance its digital platform, and potentially broaden its reach to new markets or patient populations. This funding will likely support research and development, strategic partnerships, and the enhancement of its chronic disease reversal programs, solidifying its role in the evolving digital health landscape.
See full AndHealth company page
